tiprankstipranks
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market
CADL
Candel Therapeutics
RESEARCH TOOLSreports

Candel Therapeutics (CADL) Income Statement

440 Followers

Candel Therapeutics Income Statement

Last quarter (Q4 2025), Candel Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Candel Therapeutics's net income was $-29.50M. See Candel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 125.00K$ 125.00K
Gross Profit
$ -845.00K$ -990.00K$ -23.98M$ 125.00K$ -14.47M
Operating Expenses
$ 47.42M$ 32.38M$ 14.41M$ 34.85M$ 11.26M
Depreciation and Amortization
$ 845.00K$ 990.00K$ 960.00K$ 778.00K$ 232.00K
EBITDA
$ -47.42M$ -52.10M$ -37.43M$ -16.31M$ -25.49M
Operating Income
$ -48.27M$ -33.37M$ -38.39M$ -34.72M$ -25.73M
Other Income/Expenses
$ 10.08M$ -21.81M$ 452.00K$ 15.93M$ -10.40M
Pretax Income
$ -38.18M$ -55.18M$ -37.94M$ -18.79M$ -36.12M
Net Income
$ -38.18M$ -55.18M$ -37.94M$ -18.79M$ -36.12M
Per Share Metrics
Basic EPS
$ -0.72$ -1.74$ -1.31$ -0.10$ -1.26
Diluted EPS
$ -0.72$ -1.74$ -1.31$ -0.10$ -1.26
Weighted Average Shares Outstanding
 52.96M 31.68M 28.94M 28.82M 28.69M
Weighted Average Shares Outstanding (Diluted)
 52.96M 31.68M 28.94M 28.82M 28.69M
Currency in USD

Candel Therapeutics Earnings and Revenue History